Successful treatment of onychomycosis with fluconazole in two patients with hyperimmunoglobulin E syndrome.
We report two patients with hyperimmunoglobulin E syndrome who had fingernail onychomycosis and were successfully treated with fluconazole. Relapse of oral candidiasis, but not of onychomycosis, was observed within three months of stopping fluconazole. There were no adverse effects from this therapy. Based on our experience, we think that fluconazole may be useful in the treatment of onychomycosis in patients with hyper-IgE syndrome as well as in those with other primary immunodeficiency disorders.
Aihara
Y
Y
Department of Pediatrics, Yokohama City University, School of Medicine, Japan.
Mori
M
M
Yokota
S
S
D000293:Adolescent; D000935:Antifungal Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D006229:Hand Dermatoses / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007589:Job Syndrome / Q000150:complications*; D008297:Male; D014009:Onychomycosis / Q000188:drug therapy* / Q000209:etiology
D000935:Antifungal Agents; D015725:Fluconazole